196 related articles for article (PubMed ID: 35649647)
21. Hippocampal [
Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
[TBL] [Abstract][Full Text] [Related]
22. Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL
Krishnadas N; Doré V; Robertson JS; Ward L; Fowler C; Masters CL; Bourgeat P; Fripp J; Villemagne VL; Rowe CC
EBioMedicine; 2023 Feb; 88():104450. PubMed ID: 36709581
[TBL] [Abstract][Full Text] [Related]
23. [
Blazhenets G; Soleimani-Meigooni DN; Thomas W; Mundada N; Brendel M; Vento S; VandeVrede L; Heuer HW; Ljubenkov P; Rojas JC; Chen MK; Amuiri AN; Miller Z; Gorno-Tempini ML; Miller BL; Rosen HJ; Litvan I; Grossman M; Boeve B; Pantelyat A; Tartaglia MC; Irwin DJ; Dickerson BC; Baker SL; Boxer AL; Rabinovici GD; La Joie R
J Nucl Med; 2023 Dec; 64(12):1980-1989. PubMed ID: 37918868
[TBL] [Abstract][Full Text] [Related]
24. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
[TBL] [Abstract][Full Text] [Related]
25. Optimizing quantification of MK6240 tau PET in unimpaired older adults.
Harrison TM; Ward TJ; Murphy A; Baker SL; Dominguez PA; Koeppe R; Vemuri P; Lockhart SN; Jung Y; Harvey DJ; Lovato L; Toga AW; Masdeu J; Oh H; Gitelman DR; Aggarwal N; Snyder HM; Baker LD; DeCarli C; Jagust WJ; Landau SM;
Neuroimage; 2023 Jan; 265():119761. PubMed ID: 36455762
[TBL] [Abstract][Full Text] [Related]
26. Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden.
Bourgeat P; Krishnadas N; Doré V; Mulligan R; Tyrrell R; Bozinovski S; Huang K; Fripp J; Villemagne VL; Rowe CC
J Prev Alzheimers Dis; 2023; 10(2):251-258. PubMed ID: 36946452
[TBL] [Abstract][Full Text] [Related]
27. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand
Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT
J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006
[TBL] [Abstract][Full Text] [Related]
28. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.
Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH
J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651
[TBL] [Abstract][Full Text] [Related]
29. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
Marquié M; Verwer EE; Meltzer AC; Kim SJW; Agüero C; Gonzalez J; Makaretz SJ; Siao Tick Chong M; Ramanan P; Amaral AC; Normandin MD; Vanderburg CR; Gomperts SN; Johnson KA; Frosch MP; Gómez-Isla T
Acta Neuropathol Commun; 2017 Oct; 5(1):75. PubMed ID: 29047416
[TBL] [Abstract][Full Text] [Related]
30. The spatial extent of tauopathy on [
Gérard T; Colmant L; Malotaux V; Salman Y; Huyghe L; Quenon L; Dricot L; Ivanoiu A; Lhommel R; Hanseeuw B
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1662-1674. PubMed ID: 38228971
[TBL] [Abstract][Full Text] [Related]
31. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
Malarte ML; Gillberg PG; Kumar A; Bogdanovic N; Lemoine L; Nordberg A
Mol Psychiatry; 2023 Mar; 28(3):1272-1283. PubMed ID: 36447011
[TBL] [Abstract][Full Text] [Related]
32. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
33. Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals.
Biel D; Brendel M; Rubinski A; Buerger K; Janowitz D; Dichgans M; Franzmeier N;
Alzheimers Res Ther; 2021 Aug; 13(1):137. PubMed ID: 34384484
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.
Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S
JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372
[TBL] [Abstract][Full Text] [Related]
35. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
[TBL] [Abstract][Full Text] [Related]
36. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography.
Wang YT; Edison P
Curr Neurol Neurosci Rep; 2019 Jun; 19(7):45. PubMed ID: 31172290
[TBL] [Abstract][Full Text] [Related]
37. Tau PET imaging in neurodegenerative tauopathies-still a challenge.
Leuzy A; Chiotis K; Lemoine L; Gillberg PG; Almkvist O; Rodriguez-Vieitez E; Nordberg A
Mol Psychiatry; 2019 Aug; 24(8):1112-1134. PubMed ID: 30635637
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
[TBL] [Abstract][Full Text] [Related]
39. [
Lagarde J; Olivieri P; Caillé F; Gervais P; Baron JC; Bottlaender M; Sarazin M
J Neurol; 2019 Dec; 266(12):3087-3097. PubMed ID: 31535269
[TBL] [Abstract][Full Text] [Related]
40. Tau PET Imaging.
Higuchi M
Adv Exp Med Biol; 2019; 1184():217-230. PubMed ID: 32096041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
